YD Bio (NASDAQ:YDES) Shares Gap Down – Time to Sell?

YD Bio Limited (NASDAQ:YDES)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $8.80, but opened at $8.03. YD Bio shares last traded at $8.50, with a volume of 1,756 shares traded.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. Wall Street Zen upgraded YD Bio to a “sell” rating in a research report on Tuesday, November 4th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

YD Bio Price Performance

The firm’s 50-day moving average is $11.36.

Institutional Investors Weigh In On YD Bio

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC grew its stake in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,363 shares of the biotechnology company’s stock after acquiring an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.